Thus, the combined effects of increased PKC signaling, dopamine dysregulation, serotonin involvement, and α-synuclein aggregation form a complex network that accelerates neuroinflammation, proteinopathy, and neurodegeneration, ultimately contributing to the onset and progression of AD. This evidence concerns the gene PRRT2 and Alzheimer disease.